A young woman points to the Omnipod 5 device on her arm

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/24262035/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/3e9ccc/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/Ep_508_Final_Omipod_Panel_and_Med_Director.mp3″ libsyn_item_id=”24262035″ height=”90″ theme=”custom” custom_color=”3e9ccc” player_use_thumbnail=”use_thumbnail” use_download_link=”use_download_link” download_link_text=”Download” /] Omnipod 5 was approved earlier this year and just rolled out to a wider release. So how is the first tubeless automated insulin delivery system doing in the real world? We put together a panel of early adopters and got their feedback. That was great, but it brought up quite a few questions, so we reached out to Omnipod for clarification and follow up. The result is a super-sized episode full of info!

Our panel: Liat Kochavi, mother an almost-8-year-old with T1D, Stephanie Williams, mother of a teen with type 1, and Sam Durante who was diagnosed with type 1 just before she turned 16. You’ll also here from Insulet’s Director of Medical Affairs Alex Nyugen, RD, CDCES.

FYI, we were fortunate to speak with Insulet earlier this year, just after the FDA approval, and really went point by point through Omnipod 5. So we’re not rehashing everything here. If you missed that episode, here’s the link: Omnipod 5 interview from Feb 2022

Check out Stacey’s book: The World’s Worst Diabetes Mom!

Join the Diabetes Connections Facebook Group!

Sign up for our newsletter here

—–

Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
—–

Episode Transcription Below (or coming soon!)

Please visit our Sponsors & Partners – they help make the show possible!

*Click here to learn more about OMNIPOD*

*Click here to learn more about AFREZZA*

*Click here to learn more about DEXCOM*

Leave a Reply